127 related articles for article (PubMed ID: 7604643)
1. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.
Zöller M; Rembeck B; Akesson HO; Angervall L
Acta Derm Venereol; 1995 Mar; 75(2):136-40. PubMed ID: 7604643
[TBL] [Abstract][Full Text] [Related]
2. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
3. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
[TBL] [Abstract][Full Text] [Related]
4. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
Rasmussen SA; Yang Q; Friedman JM
Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
[TBL] [Abstract][Full Text] [Related]
5. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).
Masocco M; Kodra Y; Vichi M; Conti S; Kanieff M; Pace M; Frova L; Taruscio D
Orphanet J Rare Dis; 2011 Mar; 6():11. PubMed ID: 21439034
[TBL] [Abstract][Full Text] [Related]
6. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.
Evans DG; O'Hara C; Wilding A; Ingham SL; Howard E; Dawson J; Moran A; Scott-Kitching V; Holt F; Huson SM
Eur J Hum Genet; 2011 Nov; 19(11):1187-91. PubMed ID: 21694737
[TBL] [Abstract][Full Text] [Related]
7. Early cardiac morphologic and functional changes in neurofibromatosis type 1 hypertensives: an echocardiographic and tissue Doppler study.
Tedesco MA; Di Salvo G; Natale F; Graziano L; Grassia C; Calabrò R; Lama G
Int J Cardiol; 2005 May; 101(2):243-7. PubMed ID: 15882671
[TBL] [Abstract][Full Text] [Related]
8. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.
Khosrotehrani K; Bastuji-Garin S; Riccardi VM; Birch P; Friedman JM; Wolkenstein P
Am J Med Genet A; 2005 Jan; 132A(1):49-53. PubMed ID: 15523617
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous malignant melanoma and neurofibromatosis type 1.
Guillot B; Dalac S; Delaunay M; Baccard M; Chevrant-Breton J; Dereure O; Machet L; Sassolas B; Zeller J; Bernard P; Bedane C; Wolkenstein P;
Melanoma Res; 2004 Apr; 14(2):159-63. PubMed ID: 15057048
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension associated with neurofibromatosis type 1.
Jutant EM; Girerd B; Jaïs X; Savale L; O'Connell C; Perros F; Sitbon O; Humbert M; Montani D
Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30158278
[TBL] [Abstract][Full Text] [Related]
13. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
14. Heart rhythm in patients with neurofibromatosis type 1.
Malmcrona R; Zöller M; Rembeck B
Cardiology; 1996; 87(4):300-2. PubMed ID: 8793163
[TBL] [Abstract][Full Text] [Related]
15. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
Stewart DR; Cogan JD; Kramer MR; Miller WT; Christiansen LE; Pauciulo MW; Messiaen LM; Tu GS; Thompson WH; Pyeritz RE; Ryu JH; Nichols WC; Kodama M; Meyrick BO; Ross DJ
Chest; 2007 Sep; 132(3):798-808. PubMed ID: 17573495
[TBL] [Abstract][Full Text] [Related]
16. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis 1-associated neuropathies: a reappraisal.
Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
[TBL] [Abstract][Full Text] [Related]
18. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
[TBL] [Abstract][Full Text] [Related]
19. [Natural evolution of neurocutaneous syndrome in adults].
Pou Serradell A
Rev Neurol; 1996 Sep; 24(133):1085-127. PubMed ID: 8755348
[TBL] [Abstract][Full Text] [Related]
20. [Deaths in a Tunisian psychiatric hospital: an eleven-year retrospective study].
Zgueb Y; Jomli R; Ouertani A; Hechmi S; Ouanes S; Nacef F; Banaser A
Encephale; 2014 Oct; 40(5):416-22. PubMed ID: 25132014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
